Despite notable advances in cancer prevention, screening, and treatment, not all individuals benefit equally from this important progress. This fact sheet provides an overview of current health disparities in cancer care and a snapshot of ACS CAN federal advocacy activities to eliminate these disparities and achieve health equity.
Recommendations for FDA's Office of Minority Health and Health Equity (OMHHE)
In response to a request from FDA, ACS CAN has provided recommendations for areas of focus for the Office of Minority Health and Health Equity (OMHHE). Recommendations include assessing the applicability of drug "snapshot" data, evaluating the appropriateness of aggregating racial groups for analysis, and examination of drug classes where differences in metabolism, safety or efficacy are likely to be seen.